Discovery of Potent Competitive Antagonists and Positive Modulators of the P2X2 Receptor-Reference-Cited by-同舟云学术

Discovery of Potent Competitive Antagonists and Positive Modulators of the P2X2 Receptor

Published:2011-01-05 Issue:3 Volume:54 Page:817-830
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Baqi Younis¹,Hausmann Ralf²,Rosefort Christiane²,Rettinger Jürgen³,Schmalzing Günther²,Müller Christa E.¹

Affiliation:

1. PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical Chemistry I, Pharmaceutical Sciences Bonn (PSB), University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany

2. Department of Molecular Pharmacology, RWTH Aachen University, Wendlingweg 2, D-52074 Aachen, Germany

3. MultiChannelSystems MCS GmbH, Aspenhausstrasse 21, D-72770 Reutlingen, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm1012193

Reference64 articles.

1. Physiology and Pathophysiology of Purinergic Neurotransmission

2. P2 Receptors Activated by Uracil Nucleotides - An Update

3. Structure−Activity Relationships of Adenine and Deazaadenine Derivatives as Ligands for Adenine Receptors, a New Purinergic Receptor Family

4. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular ATP inhibits excitatory synaptic input on parvalbumin positive interneurons and attenuates gamma oscillations via P2X4 receptors;British Journal of Pharmacology;2024-01-31

2. Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation;Purinergic Signalling;2023-10-16

3. Rehabilitation of the P2X5 receptor: a re-evaluation of structure and function;Purinergic Signalling;2022-10-24

4. Purinergic receptors modulators: An emerging pharmacological tool for disease management;Medicinal Research Reviews;2022-05-13

5. P2X receptor antagonists and their potential as therapeutics: a patent review (2010–2021);Expert Opinion on Therapeutic Patents;2022-05-11